🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael G. Palazzolo

Brigham and Women's Hospital

ORCID: 0000-0002-2128-6752

Also affiliated with Thrombolysis in Myocardial Infarction Study Group

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.826Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

Circulation(2024)10.1161/circulationaha.123.066279
Top 24%
0.826DataRank
Top 24%27 citations

Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G. Palazzolo, Elliott M. Antman +12 more

Papers

Driven by 5 papers — median percentile 76. Top paper: “Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation”.

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

Circulation(2024)10.1161/circulationaha.123.066279
Top 24%
0.826DataRank
Top 24%27 citations

Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G. Palazzolo, Elliott M. Antman +12 more

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation(2025)10.1161/circulationaha.125.076575
N/A
0.794DataRank · unranked
37 citations

Siddharth M. Patel, Paul M. Haller, Abby L. Cange, Michael G. Palazzolo, Andrea Bellavia +23 more

Lipoprotein(a) and Benefit of Antiplatelet Therapy

JACC Advances(2023)10.1016/j.jacadv.2023.100675
N/A
0DataRank · unranked
14 citations

Marc P. Bonaca, David A. Morrow, Michael G. Palazzolo, Petr Jarolı́m, Philippe Gabríel Steg +5 more

Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin

European Heart Journal(2023)10.1093/eurheartj/ehad655.2849
N/A
0DataRank · unranked
1 citations

Michael G. Palazzolo, Elliott M. Antman, Eugene Braunwald, Anthony Carnicelli, Stuart J. Connolly +6 more

Differences Between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic Shock

Journal of Cardiac Failure(2025)10.1016/j.cardfail.2025.01.020
N/A
0DataRank · unranked
6 citations

Matthew I. Tomey, Michael G. Palazzolo, Miguel Martillo, María Ronquillo, Noah Moss +26 more